Initiate stable cell line development (June) TICK.
• PAT-DX1 solid cancer animal model data (August)
• Selection of target indication for PAT-DX1 clinical development (Q3) TICK.
• PAT-DX1 – additional solid cancer animal model data (October)
• PAT-DX1 in combination with temozolomide and radiation in brain cancer animal model (Q4)
It's all falling into place as promised..
Ann: PAT-DX1 Clinical Target Indications Confirmed, page-4
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1284114 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1116001 | 3 |
View Market Depth
| Last trade - 16.12pm 29/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable